An Australian subsidiary of Syncor has acquired Radpharm Scientific, distributor and manufacturer of diagnostic radiopharmaceuticals. Based in Canberra, Radpharm distributes its products to more than 160 nuclear medicine practices in Australia and
An Australian subsidiary of Syncor has acquired Radpharm Scientific, distributor and manufacturer of diagnostic radiopharmaceuticals. Based in Canberra, Radpharm distributes its products to more than 160 nuclear medicine practices in Australia and exports to New Zealand, Singapore, Malaysia, Thailand, and Hong Kong. The acquisition gives Syncor a presence in Canberra along with its existing sites in Sydney, Perth, and Brisbane.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.